Biotronics AI

Biotronics AI develops Bio-Q, the world’s first fully quantum computing–based drug discovery platform, designed to process large-scale genomic data for rapid and precise target identification. Bio-Q aims to reduce drug R&D timelines from years to days through quantum efficiency and precise accuracy. The company also builds open-source technologies advancing genomics, bioinformatics, cheminformatics, and drug discovery, strengthening scientific innovation across life sciences.